Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationMaría E. Figueroa, Ari Melnick, Omar Abdel‐Wahab et al.|Cancer Cell|2010Cited by 2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaJay P. Patel, Ross L. Levine, Pieter Van Vlierberghe et al.|New England Journal of Medicine|2012Cited by 1.9k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean‐François Emile, Lawrence M. Weiss, Oussama Abla et al.|Blood|2016Cited by 1.6k
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesOmar Abdel‐Wahab, Ross L. Levine, Ann Mullally et al.|Blood|2009Cited by 718
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 studyAnthony R. Mato, Michael Wang, Nirav N. Shah et al.|The Lancet|2021Cited by 456